William Sarchino
Foot & Ankle Surgery · Greenwich, NYNPI 1982647889
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,777 of the $26,091 with a category attached, or 83.5%. Accufix Surgical Inc. accounts for 92.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $13,805 and has fallen 95.8% since, to $587 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $1043.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Accufix Surgical Inc.$24K
- Prodigy Surgical Distribution, Inc.$2K
- Treace Medical Concepts, Inc.$183
- Organogenesis Inc.$90
- Stryker$74
- Amgen$15
- plus $10 from 1 others
What the payments were for
- Consulting fees$21,77783%
- Travel & lodging$2,0918%
- Food & beverage$5612%
- Education$1,6616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Accufix Surgical Inc. | 9 | $24,057 |
| Prodigy Surgical Distribution, Inc. | 2 | $1,661 |
| Treace Medical Concepts, Inc. | 6 | $183 |
| Organogenesis Inc. | 3 | $90 |
| Stryker(2 entities) | 3 | $74 |
| Amgen | 1 | $15 |
| Wishbone Medical Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accu-Joint$22,821
How this compares
$26,091 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $20,346 |
| Ciclopirox | 80 | $2,438 |
| Mupirocin | 56 | $413 |
| Cephalexin | 79 | $372 |
| Betamethasone Dipropionate | 16 | $299 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $294 |
| Silver Sulfadiazine | 39 | $289 |
| Gabapentin | 20 | $289 |
| Ketoconazole | 13 | $256 |
| SsdSilver Sulfadiazine | 19 | $148 |
| Ibuprofen | 37 | $102 |
| Levofloxacin | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Greenwich
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$328K
- Stuart MogulNew York$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.